Acute anterior uveitis following intravitreal injection of bevacizumab.
To report five cases of iritis after intravitreal injection of bevacizumab. The clinical charts of patients who received intravitreal injections of bevacizumab or ranibizumab from January 2009 to September 2011 by one physician were retrospectively reviewed. A total of 1,097 injections of bevacizumab and 571 of ranibizumab were administered. Five patients developed acute anterior uveitis and presented with severe pain, photophobia, conjunctival injection, and anterior chamber reaction 2 to 24 hours after intravitreal injection of bevacizumab. All five patients were treated with topical corticosteroids with rapid resolution of the inflammation. Although uncommon, acute iritis is a complication of intravitreal injection of bevacizumab.